Genethon, a pioneer and leader in gene therapy for rare diseases, unveiled results at the MDA Conference in Orlando confirming the long-term efficacy of its GNT0004 gene therapy in Duchenne muscular ...
Heart MRI and routine health checks revealed previously unknown cardiac, noncardiac, and other clinical issues in 89% of adults aged 75-77 years, with some requiring immediate follow-up. Researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results